Stockreport

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript [Yahoo! Finance]

VistaGen Therapeutics, Inc.  (VTGN) 
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vistagen.com
PDF Reported EPS is $-0.22, expectations were $-0.31. VTGN isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here [Read more]